Letter: the therapeutic potential of targeting CCL25/CCR9 in colonic inflammatory bowel disease - reading between the lines

Affiliations

• ¹ National Institute of Health Research (NIHR) Birmingham, Liver Biomedical Research Unit (BRU), Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. p.j.trivedi@bham.ac.uk.
• ² Liver Unit, University Hospitals Birmingham Queen Elizabeth, Birmingham, UK. p.j.trivedi@bham.ac.uk.
• ³ Department of Internal Medicine IV, Gastroenterology, Hepatology, and Infectious Diseases, Jena University Hospital, Jena, Germany.